Clinical Trials Directory

Trials / Completed

CompletedNCT06606522

A Clinical Diagnostic System for Intrinsic Acute Kidney Disease

A Diagnostic System of Clincial Model and Urinary Biomarkers for Intrinsic Acute Kidney Disease

Status
Completed
Phase
Study type
Observational
Enrollment
1,360 (actual)
Sponsor
Peking University First Hospital · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational cross-sectional study is to develop a clinical diagnostic system for intrinsic acute kidney disease (AKD) to help clincians make non-invasive diagnosis when a kidney biopsy is not available. The main questions it aims to answer are: 1. Can a clinical model comprised of common clinical indexes help diagnose AKD ? 2. Can a combinition of several urinary biomarkers help diagnose AKD ? The study will be conducted in retrospective cohorts of patients with AKD undergoing kidney biopsy. The gold standard of the study is histological diagnosis of AKD. The model will be developed in a derivation cohort from one center, and will be further externally validated in a multicent cohort. The urinary biomarkers will only be tested in the derivation cohort.

Detailed description

Acute kidney disease is a frequent syndrome characterized by a sudden loss of kidney function. AKD caused by intrinsic kidney diseases are usually more severe than other causes. The treatment of intrinsic AKD mostly depends on a definite pathological diagnosis, requiring invasive kidney biopsy which is not available in all AKD cases. The goal of this study is to develop a clinical diagnostic system comprised of clinical model and urinary biomarkers for intrinsic AKD to help clincians make non-invasive diagnosis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTClinical modelClinical model: a clinical model based on basic demorgraphic information and commonly executed laboratory tests to differentiate different pathological types of intrinsic AKD.
DIAGNOSTIC_TESTUrinary biomarkersUrinary biomarkers: biomarkers help differentiate different pathological types of intrinsic AKD.

Timeline

Start date
2024-06-01
Primary completion
2024-06-30
Completion
2024-09-09
First posted
2024-09-23
Last updated
2024-09-23

Locations

5 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06606522. Inclusion in this directory is not an endorsement.